1Y Close · As of Aug 26, 2026
JEONJINBIO operates in the Chemicals sector.
Legal name: JEONJINBIO CO., LTD.
In fiscal year 2025, JEONJINBIO (110020) reported revenue of 13.7 billion KRW, down 28.9% from 19.3 billion KRW a year earlier.
Operating profit was -343 million KRW and net income was -196 million KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 17.7 billion KRW, with a P/B of 1.02.
These figures can be verified in the DART filing (receipt no. 20260316001483).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 13.7B | -343M | -196M |
| 2024 | 19.3B | 1.2B | 4.3B |
| 2023 | 15.7B | -1.2B | -6.4B |
Recent Filings
Officer/Major Shareholder Ownership Report
Large Shareholding Report (General)
Semi-Annual Report (2026.06)
Checks
1 of 8 checked items currently applicable.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-21 | Officer/Major Shareholder Ownership Report |
| 2026-08-21 | Large Shareholding Report (General) |
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-11 | Officer/Major Shareholder Ownership Report |
| 2026-08-11 | Large Shareholding Report (General) |